KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Gilead Sciences (GILD) over the last 12 years, with Q3 2025 value amounting to $995.0 million.

  • Gilead Sciences' Dividends Paid - Common rose 184.24% to $995.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year increase of 210.63%. This contributed to the annual value of $3.9 billion for FY2024, which is 272.68% up from last year.
  • As of Q3 2025, Gilead Sciences' Dividends Paid - Common stood at $995.0 million, which was up 184.24% from $997.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Dividends Paid - Common registered a high of $1.0 billion during Q1 2025, and its lowest value of $903.0 million during Q2 2021.
  • Over the past 5 years, Gilead Sciences' median Dividends Paid - Common value was $953.0 million (recorded in 2023), while the average stood at $953.2 million.
  • Per our database at Business Quant, Gilead Sciences' Dividends Paid - Common skyrocketed by 491.99% in 2021 and then soared by 184.24% in 2025.
  • Over the past 5 years, Gilead Sciences' Dividends Paid - Common (Quarter) stood at $904.0 million in 2021, then grew by 2.65% to $928.0 million in 2022, then grew by 2.16% to $948.0 million in 2023, then grew by 2.64% to $973.0 million in 2024, then increased by 2.26% to $995.0 million in 2025.
  • Its last three reported values are $995.0 million in Q3 2025, $997.0 million for Q2 2025, and $1.0 billion during Q1 2025.